Search

Shannon Odelberg Phones & Addresses

  • 1661 E 900 S, Salt Lake City, UT 84105
  • Salt Lake Cty, UT
  • Grand Junction, CO

Work

Position: Production Occupations

Education

Degree: Associate degree or higher

Business Records

Name / Title
Company / Classification
Phones & Addresses
Shannon J. Odelberg
Cardiovascular
U-U Cardiology Division
General Medical and Surgical Hospitals, Nsk
50 N Medical Dr, Salt Lake City, UT 84132
PO Box 413033, Salt Lake City, UT 84141

Publications

Us Patents

Compositions And Methods For Cell Dedifferentiation And Tissue Regeneration

View page
US Patent:
2003021, Nov 13, 2003
Filed:
Apr 4, 2003
Appl. No.:
10/275828
Inventors:
Mark Keating - Newton MA,
Shannon Odelberg - Salt Lake City UT,
Kenneth Poss - Brookline MA,
International Classification:
A61K048/00
C12N005/08
C12N015/85
US Classification:
514/044000, 435/455000, 435/366000
Abstract:
The present invention is directed to methods and compositions to induce cellular dedifferentiation and tissue regeneration in vitro and in vivo.

Compositions And Methods For Cell Dedifferentiation And Tissue Regeneration

View page
US Patent:
2004008, May 6, 2004
Filed:
Nov 22, 2002
Appl. No.:
10/302812
Inventors:
Mark Keating - Chestnut Hill MA,
Shannon Odelberg - Salt Lake City UT,
Kenneth Poss - Brookline MA,
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
C12N005/08
A61K045/00
US Classification:
435/366000, 424/093700
Abstract:
The present invention provides methods and compositions to dedifferentiate a cell. The ability of the methods and compositions of the present invention to promote the dedifferentiation of differentiated cells, including terminally differentiated cells, can be used to promote regeneration of tissues and organs in vivo. The ability of the methods and compositions of the present invention to promote the dedifferentiation of differentiated cells, including terminally differentiated cells, can further be used to produce populations of stem or progenitor cells which can be used to promote regeneration of tissues and/or organs damaged by injury or disease. Accordingly, the present invention provides novel methods for the treatment of a wide range of injuries and diseases that affect many diverse cell types.

Compositions And Methods For Cell Dedifferentiation And Tissue Regeneration

View page
US Patent:
2008022, Sep 18, 2008
Filed:
Jul 20, 2007
Appl. No.:
11/880435
Inventors:
Mark T. Keating - Chestnut Hill MA,
Shannon J. Odelberg - Salt Lake City UT,
Kenneth D. Poss - Chapel Hill NC,
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61K 31/70
C12N 5/06
C12Q 1/02
A61P 43/00
US Classification:
514 44, 435377, 435 29
Abstract:
The present invention provides methods and compositions to dedifferentiate a cell. The ability of the methods and compositions of the present invention to promote the dedifferentiation of differentiated cells, including terminally differentiated cells, can be used to promote regeneration of tissues and organs in vivo. The ability of the methods and compositions of the present invention to promote the dedifferentiation of differentiated cells, including terminally differentiated cells, can further be used to produce populations of stem or progenitor cells which can be used to promote regeneration of tissues and/or organs damaged by injury or disease. Accordingly, the present invention provides novel methods for the treatment of a wide range of injuries and diseases that affect many diverse cell types.

Deletion In Chromosome 17P11.2-12 Which Causes The Disorder Hereditary Neuropathy With Liability To Pressure Palsies

View page
US Patent:
5645993, Jul 8, 1997
Filed:
May 18, 1995
Appl. No.:
8/443561
Inventors:
Phillip F. Chance - Philadelphia PA
Mary Kathryn Alderson - Salt Lake City UT
Shannon J. Odelberg - Salt Lake City UT
M. William Lensch - Devon PA
Assignee:
University of Utah - Salt Lake City UT
International Classification:
C12Q 168
C12P 1934
C07H 2104
C12N 1500
US Classification:
435 6
Abstract:
A method is disclosed for diagnosing Hereditary Neuropathy with Liability to Pressure Palsies (HNPP). A submicroscopic deletion of about 1. 5 million basepairs on chromosome 17p11. 2 is associated with the disorder in three unrelated pedigrees. The deletion includes all the markers known to map within the Charcot-Marie-Tooth type 1A (CMT1A) duplication. The method involves detecting the presence or absence of the deletion in DNA extracted from a patient sample. The deletion may be detected by Southern analysis or fluorescence in situ hybridization analysis (FISH). Sequences or probes that may be used to detect the deletion are provided, as are components of a kit for diagnosing HNPP.
Shannon J Odelberg from Salt Lake City, UT, age ~64 Get Report